Testing for SARS-CoV-2: Can We Stop at 2?

Adult COVID-19 / diagnosis COVID-19 Nucleic Acid Testing / methods Female Humans Male Nasopharynx / virology Radiography SARS-CoV-2 / isolation & purification Sampling Studies Thorax / diagnostic imaging Time Factors
COVID-19 SARS-CoV-2 diagnosis polymerase chain reaction testing

Journal

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213

Informations de publication

Date de publication:
19 11 2020
Historique:
received: 04 03 2020
accepted: 17 04 2020
pubmed: 20 4 2020
medline: 15 12 2020
entrez: 20 4 2020
Statut: ppublish

Résumé

The COVID-19 epidemic requires accurate identification and isolation of confirmed cases for effective control. This report describes the effectiveness of our testing strategy and highlights the importance of repeat testing in suspected cases in our cohort.

Identifiants

DOI: 10.1093/cid/ciaa459 PMID: 32306042 PMC: PMC7188180
pubmed: 32306042
pii: 5822543
doi: 10.1093/cid/ciaa459
pmc: PMC7188180
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2246-2248

Commentaires et corrections

Type : CommentIn

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Auteurs

Tau Hong Lee (TH)

National Centre for Infectious Diseases, Singapore.
Tan Tock Seng Hospital, Singapore.
Lee Kong Chian School of Medicine, Singapore.
Yong Loo Lin School of Medicine, Singapore.

Ray Junhao Lin (R)

National Centre for Infectious Diseases, Singapore.
Tan Tock Seng Hospital, Singapore.

Raymond T P Lin (RTP)

National Centre for Infectious Diseases, Singapore.

Timothy Barkham (T)

Tan Tock Seng Hospital, Singapore.
Yong Loo Lin School of Medicine, Singapore.

Pooja Rao (P)

Tan Tock Seng Hospital, Singapore.
Lee Kong Chian School of Medicine, Singapore.

Yee-Sin Leo (YS)

National Centre for Infectious Diseases, Singapore.
Tan Tock Seng Hospital, Singapore.
Lee Kong Chian School of Medicine, Singapore.
Yong Loo Lin School of Medicine, Singapore.
Saw Swee Hock School of Public Health, Singapore.

David Chien Lye (D)

National Centre for Infectious Diseases, Singapore.
Tan Tock Seng Hospital, Singapore.
Lee Kong Chian School of Medicine, Singapore.
Yong Loo Lin School of Medicine, Singapore.

Barnaby Young (B)

National Centre for Infectious Diseases, Singapore.
Tan Tock Seng Hospital, Singapore.
Lee Kong Chian School of Medicine, Singapore.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Testing for SARS-CoV-2: Can We Stop at 2?
questionsmedicales.fr › Maladies de l'appareil respiratoire › Infections de l'appareil respiratoire › Pneumopathie infectieuse › Pneumopathie virale › COVID-19 › Testing for SARS-CoV-2: Can We Stop at 2?
questionsmedicales.fr › Techniques d'investigation › Techniques de laboratoire clinique › Dépistage de la COVID-19 › Détection de l'acide nucléique du virus de la COVID-19 › Testing for SARS-CoV-2: Can We Stop at 2?
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Testing for SARS-CoV-2: Can We Stop at 2?
questionsmedicales.fr › Système stomatognathique › Pharynx › Partie nasale du pharynx › Testing for SARS-CoV-2: Can We Stop at 2?
questionsmedicales.fr › Diagnostic › Techniques et procédures diagnostiques › Imagerie diagnostique › Radiographie › Testing for SARS-CoV-2: Can We Stop at 2?
questionsmedicales.fr › Virus › Virus à ARN › Virus à ARN à brin positif › Nidovirales › Coronaviridae › Coronavirus › Betacoronavirus › Virus du SRAS › SARS-CoV-2 › Testing for SARS-CoV-2: Can We Stop at 2?
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études par échantillonnage › Testing for SARS-CoV-2: Can We Stop at 2?
questionsmedicales.fr › Régions du corps › Tronc › Thorax › Testing for SARS-CoV-2: Can We Stop at 2?
questionsmedicales.fr › Phénomènes physiques › Temps › Facteurs temps › Testing for SARS-CoV-2: Can We Stop at 2?